Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-10-04

FDA Approved: TRIHEXYPHENIDYL HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

The FDA approved a supplemental application for Trihexyphenidyl hydrochloride from PAI Holdings (PAI Pharma), establishing its generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trihexyphenidyl hydrochloride (Trihexyphenidyl hydrochloride)

Snippet

SUPPL AP for TRIHEXYPHENIDYL HYDROCHLORIDE (TRIHEXYPHENIDYL HYDROCHLORIDE)